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Abstract 24 
Vertebral lesions and associated neurological signs occur in dogs with multiple 25 
myeloma, however, veterinary literature describing magnetic resonance imaging (MRI) 26 
findings is currently lacking. The objective of this retrospective case series was to evaluate 27 
neurological signs and MRI findings in dogs with multiple myeloma, which presented for 28 
spinal pain or other neurological deficits. 29 
 30 
Electronic records of four veterinary referral hospitals were reviewed. Dogs were 31 
included on the basis they had confirmed diagnosis of multiple myeloma, had presented for 32 
spinal pain or other neurological signs, and had undergone MRI of the vertebral column. MRI 33 
studies were evaluated and the anatomical location of lesion(s), signal intensity, presence of 34 
extra-dural material, degree of spinal cord compression, extent of vertebral lesions, and 35 
contrast enhancement were recorded. 36 
 37 
Twelve dogs were included; most dogs (n = 8) had a chronic progressive history, with 38 
varying degrees of proprioceptive ataxia and paresis (n = 11), and spinal pain was a feature in 39 
all dogs. MRI findings were variable but more consistent features included the presence of 40 
multiple expansile vertebral lesions without extension beyond the outer cortical limits of 41 
affected vertebrae, and associated extradural material causing spinal cord compression. The 42 
majority of lesions were hyper- to isointense on T2 (n = 12) and T1-weighted (n = 8) 43 
sequences, with variable but homogenous contrast-enhancement (n = 12).  44 
 45 
The MRI characteristics of multiple myeloma may be used to aid early identification 46 
and guide subsequent confirmatory diagnostic steps, to ultimately improve therapeutic 47 
approach and long-term outcome.   48 
 3 
Introduction 49 
Multiple myeloma is a malignant disorder characterised by systemic proliferation of 50 
neoplastic plasma cells.1–3 This haematopoietic neoplasm has a predilection for bone marrow 51 
of the axial skeleton and is the most important myeloma-related disorder in dogs based on 52 
incidence and severity.3 Neoplastic cells involved with multiple myeloma are usually 53 
functional and secrete an overabundance of a single type or component of immunoglobulin, 54 
otherwise known as M-component.1,3 Clinical signs ultimately depend on the location of 55 
neoplastic cellular infiltration as well as circulating levels of M-component.4 Therefore, 56 
patients can present with variable or non-specific clinical signs including lethargy and 57 
weakness, which can be misleading and make diagnostic investigation challenging.1,5  58 
 59 
The criteria for diagnosis of multiple myeloma includes at least two of the following: 60 
histopathological evidence of bone marrow plasmacytosis, detection of a monoclonal 61 
gammopathy in serum or urine, detection of light chain (Bence-Jones) proteinuria, and 62 
evidence of multiple osteolytic bone lesions.2,4 Between 25-75% of dogs affected with 63 
multiple myeloma have radiographic evidence of bony lesions.3 Furthermore, approximately 64 
50% of dogs with vertebral involvement have neurological manifestation of disease; spinal 65 
pain with accompanying neurological deficits are common clinical findings.4,5 Multiple 66 
myeloma is associated with a number of other clinicopathologic abnormalities including 67 
hyperviscosity syndrome (HVS), hypercalcaemia and renal insufficiency. 1,3–5 68 
 69 
Rusbridge and colleagues (1999) previously described clinical, neurological and 70 
radiographic findings in eight dogs affected by vertebral plasma cell tumours which 71 
presented with spinal pain and other neurological deficits.2 None of the study subjects 72 
underwent magnetic resonance imaging (MRI) however. Kippenes and colleagues (1999) 73 
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previously reported MRI findings in dogs with vertebral tumours but only two of the dogs 74 
were diagnosed with vertebral plasmacytomas.6 MRI offers several advantages over 75 
radiography as a diagnostic imaging modality for investigation of spinal disease, and is 76 
considered part of the ‘gold standard’ imaging for human multiple myeloma patients.7–10 77 
Veterinary literature describing MRI findings in dogs diagnosed with multiple myeloma is 78 
currently lacking. 79 
 80 
By characterising the clinical and MRI features in dogs with multiple myeloma, this 81 
may aid early identification and guide subsequent confirmatory diagnostic steps; earlier 82 
diagnosis and treatment may improve long-term outcome.11 MRI examination features may 83 
also have prognostic implications and could prove useful in monitoring response to 84 
treatment.8–10,12 The purpose of this study was to retrospectively evaluate neurological signs 85 
and MRI findings in dogs diagnosed multiple myeloma, which presented for spinal pain or 86 
other neurological signs.  87 
 88 
 89 
Materials and Methods 90 
Selection and description of subjects 91 
The study is based on a retrospective case series design and was granted ethical 92 
approval by the Clinical Research Ethical Review Board of the primary study institution 93 
(protocol number URN 2016 1635b). The electronic records of four large veterinary referral 94 
hospitals in the UK were reviewed between March 2005 and July 2017 to identify dogs 95 
diagnosed with multiple myeloma. All study dogs were client-owned and had presented for 96 
further investigation of suspected spinal disease. Dogs were included on the basis they had a 97 
confirmed diagnosis of multiple myeloma based on previously published criteria,2,4 had 98 
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presented for spinal pain or other neurological signs with or without additional signs of 99 
systemic illness, and had undergone MRI examination of the vertebral column. Dogs were 100 
excluded if medical records or imaging studies were incomplete, or if diagnostic criteria of 101 
multiple myeloma were not met.  102 
 103 
Magnetic resonance imaging studies 104 
Although protocols and sequences could vary between institutions, MRI studies were 105 
completed with dogs under inhalational general anaesthesia using a 1.5 Tesla MRI unit 106 
(Intera, Philips Medical Systems, Eindhoven, Netherlands; Signa GE Medical Systems, 107 
Milwaukee, USA; Siemens Symphony, Camberley, UK; Siemens Magnetom, Erlangen, 108 
Germany). All dogs underwent 2D acquisition studies which included a minimum of fast 109 
spin-echo (FSE) T2-weighted (T2W) (time of repetition, TR 3000-3700ms/ time of echo, TE 110 
83-120ms) and T1-weighted (T1W) (TR 400-620ms/ TE 8-15ms) sequences. FSE T1-111 
weighted sequences were also completed immediately following manual administration of 112 
intravenous gadolinium (T1WGd) (0.1mmol/kg gadopentetate dimeglumine). Sequences in 113 
sagittal and transverse planes were available in all dogs. Slice thickness was 2-4mm with an 114 
inter-slice gap of 2.3-4.3mm in the sagittal plane, and slice thickness was 2-5mm with an 115 
inter-slice gap of 3.3-5.3mm in the transverse plane. Where available, short-tau inversion 116 
recovery sequences (STIR) (TR 8.2-26ms/ TE 50-3420ms) were reviewed. All imaging 117 
studies were assessed using a PACS workstation DICOM viewer (Osirix Imaging Software, 118 
version 3.9.2, Bernex, Switzerland). MRI sequences were independently reviewed and 119 
described by a board-certified neurologist (E.B.), and a board-certified radiologist (M.P.), 120 
blinded to the clinical history and presenting signs of each case. Anatomical location of 121 
lesion(s), signal intensity, presence of extra-dural material, degree of spinal cord 122 
compression, extent of vertebral lesions, and contrast enhancement were recorded. Signal 123 
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intensity was subjectively categorised as hyperintense, isointense, or hypointense relative to 124 
normal spinal cord. The postcontrast enhancement was subjectively categorised as mild when 125 
there was contrast enhancement that was hypointense compared to fat tissue on T1W 126 
sequences, and marked when the contrast enhancement was isointense to fat tissue on T1W 127 
sequences. The contrast enhancement was categorized as homogenous when there was 128 
uniform enhancement and heterogeneous when it was dissimilar throughout the enhanced 129 
area. Extent of vertebral lesions was based on the presence of signal intensity changes 130 
involving one-third, two-thirds, or the entire vertebral structure. Furthermore, the character of 131 
vertebral lesions was recorded as either remaining largely within the outer cortical limits of 132 
affected vertebrae, or extending beyond them. Finally, degree of spinal cord compression was 133 
subjectively graded as mild, moderate or marked if there was a reduction in < 25%, < 50% or 134 
> 50% respectively in cross-sectional area of the spinal cord, as measured in transverse 135 
section at the point of maximal compression. 136 
 137 
Data recording and analysis  138 
Information retrieved from medical records included: signalment, history, general 139 
physical and neurological examination at presentation, MRI examination findings, results of 140 
any adjunctive imaging studies (ultrasound, radiography, computed tomography (CT)), 141 
histopathology results, and bone marrow aspirate findings. Post mortem reports where 142 
available were reviewed. At the time of initial presentation all dogs were fully examined and 143 
their neurological status recorded by a board-certified neurologist or neurology resident-in-144 
training under supervision. Dogs were retrospectively assigned a neurological grade at initial 145 
presentation (S.W.). Neurological grade was based on a previously validated system for 146 
evaluation of myelopathies as follows: 0, paraplegia with absent deep nociception; 1, 147 
paraplegia with absent superficial nociception; 2, paraplegia/ tetraplegia with intact 148 
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nociception; 3, non-ambulatory paraparesis/ tetraparesis; 4, ambulatory paraparesis/ 149 
tetraparesis and ataxia; 5, spinal pain only; and 6, no dysfunction.13  150 
 151 
 152 
Results 153 
Case Subjects 154 
 Twelve dogs were included in the study. Dogs had a mean age of 7.7 years at initial 155 
presentation (median: 7.3 years, range: 4.4 - 11.9 years) and a mean body weight of 29 kg 156 
(median: 28.0 kg, range: 19 - 47 kg).  Eight dogs were male (six neutered) and four were 157 
female (two neutered). Breeds included Golden Retriever (n = 3), Staffordshire Bull Terrier 158 
(n = 2), Cross Breed (n = 1), Doberman (n = 1), Scottish Terrier (n = 1), Cocker Spaniel (n = 159 
1), Flat Coat Retriever (n = 1), Beagle (n = 1), and Rottweiler (n = 1).   160 
 161 
Clinical Presentation 162 
Duration of clinical signs prior to presentation ranged from one to 42 days (median: 163 
14 days). Most dogs (n = 8) had a chronic progressive history, often with varying degrees of 164 
proprioceptive ataxia and paresis (n = 11), and spinal pain was a feature in all dogs. Onset of 165 
clinical signs was classified as acute and progressive in a further three dogs. One dog 166 
presented with a peracute onset paraplegia with intact nociception; this dog was diagnosed 167 
with a pathological compression fracture of the vertebral body of T10 in addition to a 168 
diagnosis of multiple myeloma. Neuroanatomical localisation varied but, in most dogs, 169 
clinical signs were consistent with a single neuroanatomical localisation (n = 8), and most 170 
frequently involved T3-L3 spinal cord segments (n = 7). One other dog exhibited signs 171 
consistent with a single neuroanatomical localisation which involved L4-S3 spinal cord 172 
segments. Four dogs demonstrated clinical signs which were consistent with a lesion 173 
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involving two different neuroanatomical locations based on neurological deficits and 174 
presence of spinal pain; these included C1-C5 and C6-T2 spinal cord segments in three dogs, 175 
and C1-C5 and L4-S3 spinal cord segments in one dog. An equal proportion of dogs showed 176 
evidence of lateralisation of clinical signs. Most dogs (n = 9) were assigned to grade 4 177 
neurological status at initial presentation. One dog presented with spinal pain only and was 178 
therefore assigned a grade 5. One dog presented with non-ambulatory paraparesis and was 179 
therefore assigned a grade 3. One dog presented paraplegic with intact nociception and was 180 
assigned a grade 2. Regarding non-neurological findings, one dog presented with marked 181 
polyuria and polydipsia and was diagnosed with IRIS stage III renal failure,14 two dogs had 182 
intermittent pyrexia, and eight dogs demonstrated non-specific signs of lethargy and 183 
inappetence. 184 
 185 
Imaging Findings 186 
Solitary vertebral lesions were identified in three dogs (25%) while in the remaining 187 
nine dogs (75%), multiple vertebral lesions were identified on MRI. The most frequently 188 
affected region was T3-L3 vertebrae with all dogs demonstrating some evidence of 189 
pathological change. Seven dogs (58%) each had involvement of C1-C5 vertebrae and L4-S3 190 
vertebrae, while five dogs (42%) had involvement of C6-T2 vertebrae. Eight dogs (67%) had 191 
lesions in more than one region of the vertebral column.  192 
 193 
MRI appearance of vertebral lesions was associated with variable signal changes 194 
which showed no association with duration of clinical signs prior to presentation or any other 195 
clinical data. On T2W sequences, vertebral lesions were hyperintense in four dogs (33%), 196 
hyper- to isointense in seven dogs (58%), and isointense in one dog when compared to 197 
normal spinal cord (Fig. 1A, 2, 3A). On T1W sequences, vertebral lesions were hyperintense 198 
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in four dogs (33%), hyper- to isointense in three dogs (25%), iso- to hypointense in four dogs 199 
(33%), and isointense in one dog when compared to normal spinal cord (Fig. 1B, 3B). 200 
Additional STIR sequences were completed in eleven dogs and revealed lesions as 201 
hyperintense when compared to normal spinal cord in all of them (Fig. 3C). Contrast 202 
enhancement was present in all cases and was variable in intensity (from mild to marked) but 203 
homogeneous (Fig. 1C, 3D). Vertebral lesions were often asymmetrical, and although lesions 204 
variably affected all parts of the vertebrae, the vertebral body and arch tended to be more 205 
frequently involved. Lesions were often extensive involving two-thirds of vertebral structure 206 
in six dogs and the entire vertebral structure in three dogs. Vertebral lesions were generally 207 
consistent with expansile mass lesions which did not extend beyond the outer cortical limits 208 
of affected vertebra (n = 9) and were responsible for varying degrees of spinal cord 209 
compression (Fig. 1). The degree of spinal cord compression was categorised as moderate (n 210 
= 6) or marked (n = 6) and there was no association with neurological grade at presentation. 211 
One dog was also found to have a compression fracture of the vertebral body of T10.  212 
 213 
In all cases on MRI there was evidence of extradural material extending into the 214 
vertebral canal causing variable spinal cord compression (Fig. 1). This was detected at a 215 
single site in eight dogs (67%) or multiple sites in four dogs (33%), and when present was 216 
always found at the same site as a vertebral lesion. Location of extradural material was in the 217 
region of T3-L3 vertebrae in nine dogs (75%). Other regions included C1-C5 vertebra in four 218 
dogs (33%), C6-T2 vertebra in five dogs (42%) and L4 vertebra to sacral vertebra in five 219 
dogs (42%). Extradural material was hyperintense in six dogs (50%), hyper- to isointense in 220 
five dogs (42%) and isointense in one dog when compared to normal spinal cord on T2W 221 
sequences. On T1W sequences, extradural material was hyperintense in seven dogs (58%), 222 
hyper- to isointense in four dogs (33%) and isointense in one dog when compared to normal 223 
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spinal cord. Mild to marked homogenous contrast enhancement of extradural material was 224 
present in all cases. MRI also identified additional bony lesions affecting ribs (n = 2), 225 
occipital bone of the skull (n = 1) and scapula (n = 2), along with enlarged thoracic lymph 226 
nodes and hepatic nodules in one case. 227 
 228 
Three dogs had CT imaging of the abdomen and thorax following MRI. In two cases, 229 
this revealed further vertebral lesions in addition to those identified on MRI, as well as other 230 
lesions affecting ribs (n = 1), sacrum (n = 1), scapula (n = 1), and the ileum of the pelvis (n = 231 
1). Seven dogs had radiographic imaging of the abdomen, thorax and vertebral column; 232 
lesions were identified affecting ribs, sternum, scapula, sacrum and pelvis and were 233 
consistent with those identified on MRI. Four dogs had abdominal ultrasound following MRI 234 
which revealed mass lesions affecting the liver (n = 2) and spleen (n = 1); cytological 235 
evaluation of fine needle aspirate samples collected from lesions was consistent with a 236 
diagnosis of round cell neoplasia in all cases.  237 
 238 
Confirmatory antemortem histopathological diagnosis was achieved in nine dogs 239 
following biopsy of bony lesions taken from a variety of sites, as identified on diagnostic 240 
imaging studies. Biopsy sites included ileum of the pelvis, vertebrae, rib, and scapula. Four 241 
dogs were euthanised shortly after diagnosis; post mortem examination was consistent with a 242 
diagnosis of multiple myeloma in all cases.  243 
 244 
 245 
Discussion 246 
This study documents the neurological signs and MRI characteristics of dogs with 247 
multiple myeloma which presented with spinal pain or other neurological deficits. Although 248 
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there was a significant amount of variability in imaging characteristics detected on MRI, 249 
some more consistent features identified were the presence of extradural material and 250 
multiple expansile vertebral lesions which did not extend beyond the outer cortical limits of 251 
affected vertebra, and that were hyper- to isointense on T2W and T1W sequences, and 252 
variably but homogenously contrast-enhancing. The imaging features identified in this study 253 
may help to distinguish multiple myeloma from other differential diagnosis which include 254 
primary vertebral tumours or other less likely causes such as osteomyelitis. In comparison to 255 
multiple myeloma, vertebral neoplasms of an osseous lineage often disrupt cortices of 256 
affected vertebrae due to bony lysis and proliferation.11 Primary bone tumours also more 257 
frequently involve a single vertebrae in comparison to multiple myeloma which typically 258 
resulted in involvement of multiple vertebral segments.11 Regarding pathological signal 259 
intensity changes, replacement of normal bone marrow by oedema and inflammatory or 260 
neoplastic cells increases T2W relaxation and is reflected as areas of high signal intensity on 261 
T2W sequences.19  These same pathological changes account for decreased T1W relaxation 262 
and hence reveal corresponding areas of low signal intensity, as in the case of osteomyelitis 263 
or other vertebral neoplastic lesions.6,19,20 An unusual feature associated with multiple 264 
myeloma however was the fact most lesions showed variable evidence of hyperintensity on 265 
T1W sequences, which could be used as an additional identifying feature. This is consistent 266 
with previous reports which demonstrated that vertebral plasmacytomas were hyperintense 267 
on T1W sequences when compared to spinal cord parenchyma and when also compared to 268 
other types of vertebral tumour; one possible explanation is the presence of haemorrhage 269 
within myelomatous lesions of the vertebral bone marrow.6,12,21 Other studies in the human 270 
literature have suggested that bone marrow fat cell content of patients affected with early 271 
stage multiple myeloma may be increased, which may account for the relative T1W 272 
hyperintensity of lesions in certain patients.8,10 In the current study this theory was not 273 
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supported as corresponding areas were hyperintense on STIR sequences and no association 274 
could be found with any imaging characteristics and duration of clinical signs prior to 275 
presentation. Repeat imaging to compare and monitor progression of lesion intensity, 276 
utilisation of additional MRI sequences such as T2W gradient echo, or histopathological 277 
evaluation of lesions would be beneficial to help determine the cause of signal intensity 278 
changes. The unique imaging features identified in this study may help to distinguish 279 
multiple myeloma from other types of vertebral neoplastic or other less likely infectious 280 
lesions and guide subsequent confirmatory diagnostic steps. 6 281 
 282 
The variability in imaging characteristics in the current study may reflect the 283 
differences in pathological bony changes associated with different stages of multiple 284 
myeloma. In the human literature, between three and five imaging patterns have previously 285 
been described based on MRI examination features.8–10,12 These patterns include normal bone 286 
marrow, focal marrow lesions, diffuse homogenous marrow involvement, combined focal 287 
and diffuse marrow involvement, or variegated patterns with multiple small lesions on a 288 
background of normal marrow.8–10 Interestingly, the presence of certain MRI patterns has 289 
previously been correlated with clinicopathological changes including the percentage bone 290 
marrow plasmacytosis and haemoglobin values.12,22 In addition, MRI patterns also have 291 
reported in association with survival data and diffuse marrow infiltration has been correlated 292 
with more advanced disease features and increased tumour mass. 8,9,22,23 Due to the small 293 
numbers of cases in this study we were unable to consistently identify any specific MRI 294 
patterns or correlate lesion characteristics with outcome. Further research utilising a larger 295 
study population would be necessary to define any potential MRI patterns and their possible 296 
prognostic implications in dogs diagnosed with multiple myeloma which manifest with spinal 297 
pain or neurological signs as a presenting complaint.  298 
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 299 
In the current study, neurological signs tended to be chronic, progressive, and 300 
associated with spinal pain, which is consistent with previous reports.2,5 One dog was slightly 301 
unusual in its clinical presentation and presented with a peracute history. This dog was 302 
diagnosed with a pathological compression fracture of the vertebral body of T10 secondary to 303 
an osteolytic vertebral lesion. Pathological fractures have previously been reported in 304 
association with multiple myeloma.2 It is important to be aware of this as a potential 305 
complication and not exclude the condition as a differential diagnosis despite the uncommon 306 
acute clinical presentation. An equal proportion of cases showed evidence of lateralisation of 307 
neurological signs and neuroanatomical localisation most frequently localised to T3-L3 308 
spinal cord segments; this was consistent with imaging findings in which most lesions were 309 
identified within this region of the vertebral column. The degree of spinal cord compression 310 
did not reflect the neurological grade at presentation. This may be explained by the lack of 311 
contusive injury which is typically associated with acute spinal cord compressive lesions and 312 
can contribute to neurological deterioration. 17 Significant compression of the spinal cord can 313 
often be tolerated, particularly in those cases where it occurs slowly over an extended period, 314 
such as in the current study. 17,18  315 
 316 
The findings of the current study suggest that multiple myeloma is a condition which 317 
most frequently affects middle-aged to older dogs of medium to large breed, which is 318 
agreement with the findings from previous literature.5,15 Earlier reports suggested the German 319 
Shepherd Dog breed may be overrepresented.5 This was not something we appreciated 320 
however and this was not a breed represented in the current study. Although males 321 
constituted the majority of the study population, it is impossible to comment whether a sex 322 
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predilection exists based on the small numbers. Despite this, previous studies have suggested 323 
males may be overrepresented.16 324 
 325 
The study is inherently limited by its retrospective design. The variation in clinical 326 
approach and diagnostic imaging protocols between different study organisations may also 327 
have introduced an element of systematic bias. This could ultimately have impacted on the 328 
conclusions drawn. The small study population also limits the conclusions drawn from the 329 
data. Future work utilising a larger study population with standardised diagnostic evaluation 330 
and imaging protocol would be of benefit. Based on operator experience in the current study 331 
along with previous literature, a minimum of T2W, STIR, T1W and T1WGd sequences 332 
should be utilised as standard when performing MRI examination of cases with suspected 333 
multiple myeloma.12,24  334 
 335 
In conclusion, the majority of dogs affected by multiple myeloma with vertebral 336 
involvement present with a chronic, progressive, painful T3-L3 myelopathy. The degree of 337 
spinal cord compression did not reflect the neurological grade of dogs affected. More 338 
consistent MRI features associated with multiple myeloma include the presence of extradural 339 
material and multiple vertebral lesions which largely remain within cortical limits, and are 340 
hyper- to isointense on T2W and T1W sequences, with variable but homogenous contrast 341 
enhancement. By recognising these distinguishable imaging characteristics, this may lead to 342 
earlier diagnosis and treatment with the possibility of improving long-term outcome. Further 343 
research is needed however to define the MRI features and prognostic implications in dogs 344 
diagnosed with multiple myeloma which manifest with spinal pain and neurological signs as 345 
a presenting complaint.  346 
 347 
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Figure Legends 438 
Fig. 1. Six-year six-month male entire Cocker Spaniel, presenting with a chronic, 439 
progressive, painful, non-lateralised C1-T2 myelopathy. Transverse T2-weighted 440 
(T2W), A, T1-weighted (T1W), B, and T1W post contrast (T1WGd), C, images. Note 441 
the single vertebral lesion which does not extend beyond the cortical limits of the 442 
affected C4 vertebrae (arrow, 1A). The lesion is hyper- to isointense on T2W and T1W 443 
images relative to spinal cord, with moderate homogenous contrast enhancement. 444 
There is associated extradural material (asterisk, 1C) causing moderate spinal cord 445 
compression with extension into the left intervertebral foramen.    446 
 447 
Fig. 2. Ten-year two-month male neutered Scottish Terrier, presenting with a chronic, 448 
progressive, painful, non-lateralised T3-L3 myelopathy. Transverse T2-weighted 449 
(T2W) images at the level of L3 vertebrae, A, L4 vertebrae, B, L5 vertebrae, C, and L6 450 
vertebrae, D. There are multiple vertebral lesions which largely remain within cortical 451 
limits of affected vertebrae (asterisk). Lesions are hyper- to isointense relative to spinal 452 
cord and cause variable spinal cord compression from none to marked.   453 
 454 
Fig. 3. Ten-year eight-month male neutered Golden Retriever, presenting with chronic 455 
progressive thoracolumbar spinal pain only. Sagittal T2-weighted (T2W), A, 456 
transverse T1-weighted (T1W), B, sagittal short tau inversion recovery (STIR), C, and 457 
transverse T1W post contrast (T1WGd), D, images. Note the single vertebral lesion 458 
affecting L2 vertebral body which is hyperintense on T2W and STIR images, hyper- to 459 
isointense on T1W images relative to spinal cord, with mild homogenous contrast 460 
enhancement, and marked spinal cord compression at this level (asterisk, 1D).   461 
